Daito Pharmaceutical Co.,Ltd. (TYO:4577)
Japan flag Japan · Delayed Price · Currency is JPY
1,361.00
+1.00 (0.07%)
Aug 25, 2026, 3:30 PM JST

Daito Pharmaceutical Cash Flow Statement

Millions JPY. Fiscal year is Jun - May.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 May '25 May '24 May '23 May '22
Net Income
3,1612,9584,2185,0766,720
Depreciation & Amortization
4,3874,3323,6593,8703,313
Loss (Gain) From Sale of Assets
-3841651756
Asset Writedown & Restructuring Costs
102----
Loss (Gain) From Sale of Investments
-331-409-32687-47
Loss (Gain) on Equity Investments
85-75---
Other Operating Activities
4-571-1,111-2,405-1,820
Change in Accounts Receivable
1,334-4,8912,221-1,502-3,299
Change in Inventory
2,0212,419-2,640-1,413-1,041
Change in Accounts Payable
-874-36080253822
Change in Other Net Operating Assets
-5122,110-1,806-113466
Operating Cash Flow
9,3775,8975,1824,1554,370
Operating Cash Flow Growth
59.01%13.80%24.72%-4.92%-15.67%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 May '25 May '24 May '23 May '22
Capital Expenditures
-3,849-6,789-6,220-5,505-4,627
Sale of Property, Plant & Equipment
--65---
Cash Acquisitions
--707---
Sale (Purchase) of Intangibles
-1,368-241-56-51-106
Investment in Securities
454438335-256
Other Investing Activities
375-111-1077
Investing Cash Flow
-4,388-7,365-5,930-5,566-4,400

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 May '25 May '24 May '23 May '22
Long-Term Debt Issued
-6,0004,0003,0001,500
Total Debt Issued
-6,0004,0003,0001,500
Long-Term Debt Repaid
-3,538-3,099-2,029-1,638-1,444
Total Debt Repaid
-3,538-3,099-2,029-1,638-1,444
Net Debt Issued (Repaid)
-3,5382,9011,9711,36256
Issuance of Common Stock
---3021,527
Repurchase of Common Stock
-1,631-623-1,176-110-
Common Dividends Paid
-1,119-998-907-931-660
Other Financing Activities
-1-278-71-766
Financing Cash Flow
-6,2891,002-183616989

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 May '25 May '24 May '23 May '22
Foreign Exchange Rate Adjustments
47-54512048
Miscellaneous Cash Flow Adjustments
-1111
Net Cash Flow
-1,253-519-879-7741,008

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 May '25 May '24 May '23 May '22
Free Cash Flow
5,528-892-1,038-1,350-257
Free Cash Flow Growth
-----
Free Cash Flow Margin
10.91%-1.76%-2.21%-2.99%-0.59%
Free Cash Flow Per Share
187.93-29.32-33.08-42.65-8.39
Levered Free Cash Flow
2,273-4,444330.13-918-406.63
Unlevered Free Cash Flow
2,354-4,367355.75-910.5-401

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 May '25 May '24 May '23 May '22
Cash Interest Paid
12912640139
Cash Income Tax Paid
6408421,2652,4111,924
Change in Working Capital
1,969-722-1,423-2,490-3,852